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Methemoglobinemia (MetHb) is a rare but serious cause of
infantile cyanosis (blue baby) characterized by abnormal
levels of hemoglobin (Hb), in which the iron component of
Heme is oxidized from the ferrous (Fe2þ) to the ferric (Fe3þ)
state and unable to bind oxygen.1 This leads to functional
anemia and tissue hypoxia with all its subsequent clinical
risks.
A physiological oxidation is rapidly compensated by anti-
oxidant enzymatic systems such as NADH cytochrome b5-
reductase (methemoglobin reductase).2 If these self-protect-
ing mechanisms fail, MetHb will onset.
MetHb may be congenital (due to a hereditary deﬁciency
of methemoglobin reductase or to abnormal Hb as HbM)3 or
acquired secondary to endogenous conditions (diarrhea,
acidosis)4 or to oxidizing xenobiotics. Isolated cases of
metHb associated with metoclopramide,5 paracetamol,6
local anesthetics (as benzocaine or lidocaine/prilocaine),6–9
and dietary nitrite/nitrate10 have been reported. Among the
endogenous causes, in adult and pediatric patients, it has
been hypothesized that sepsis can cause MetHb due to the
increased production of nitric oxide (NO) stimulated by
proinﬂammatory cytokines and bacterial lipopolysacchar-
ides.11,12 Therapeutic use of inhaled NO can also cause
MetHb so that in newborns treated for persistent pulmonary
hypertension, MetHb is periodically checked.13
The aim of the study was to determine the incidence of
MetHb in neonatal intensive care unit (NICU) babies and to
identify risk factors, other than inhaled NO, to establish
which newborns admitted to the NICU should be carefully
monitored.
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Abstract Objective Methemoglobinemia (MetHb) is a rare congenital or acquired cause of
infantile cyanosis. We examined the role of MetHb in a neonatal intensive care unit
(NICU).
Study Design A retrospective observational study was conducted reviewing blood
gas analyses of hospitalized newborns over a 2-year period. MetHb-positive patients
(MetHb >1.8%) were matched with a control group for gestational age, weight,
disease, and illness severity at admission. Maternal, neonatal, clinical, and laboratory
parameters were collected and analyzed in both groups.
Results MetHb incidence was 6%. The mean MetHb in the case group was 7.2%, and
the ﬁrst positive samples were observed at a mean of 22 days of life, 6 days prior to
clinical or culture-proven sepsis. We identiﬁed low maternal age (31 vs. 34 years;
p ¼ 0.038), sepsis (90 vs. 45%; p ¼ 0.022), and protracted parenteral nutrition (46 vs.
23 days; p ¼ 0.013) as risk factors for MetHb, and early minimal enteral feeding as
protective factor (12th vs. 9th day; p ¼ 0.038).
Conclusion MetHb has a high occurrence in NICU and can be a helpful prognostic
indicator of an infectious process. Understanding and prompt identiﬁcation of MetHb
can allow pediatricians to implement a life-saving therapy.
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Materials and Methods
An Institutional Review Board approval was obtained. This
retrospective observational study was conducted reviewing
the clinical charts of infants admitted in the period between
January 2016 and December 2017 at the Department of
Sciences for Health Promotion and Mother and Child Care
“G. D’Alessandro,” University of Palermo. Blood gas analyses
of all newborns admitted to theNICU during the study period
were reviewed.
Patients who underwent NO therapy for pulmonary
hypertension and those with a diagnosed cyanotic heart
disease were excluded.
During the NICU hospitalization, MetHb values were
directly reported on arterial or arterialized capillary blood
gas analyses performed with ABL 800 ﬂex (Radiometer,
Copenhagen, Denmark) to closely monitor ventilatory gases
and electrolyte parameters.
MetHb level > 1.8% of total Hb was considered positive.
Each MetHb positive patient was matched with a control
infant for gestational age, weight, disease, and neonatal
illness severity at admission using the NICU risk score (Score
for Neonatal Acute Physiology [SNAP] II and SNAP with
Perinatal Extension [SNAPPE] II).14
Maternal, obstetrical, clinical, and pharmacological data
were analyzed.
Neonatal clinical and laboratory parameters were col-
lected from medical records at T0 (48 hours prior to MetHb
increase), T1 (day of the ﬁrst positive MetHb), and Tmax (day
of maximum value of MetHb). In the control group, T1 was
assessed on the 22nd day of life (corresponding to the mean
of days of the ﬁrst MetHb increase in the case group) and T0
on the 20th day of life.
For each infant were recorded: feeding regimen, day of
surgery, blood transfusions, pharmacological treatments
(type and duration), type and onset of infections (deﬁned
as early, late, or very late onset clinically suspected or
culture-proven sepsis), comorbidity, and mortality. In survi-
vors until hospital discharge, we considered the duration of
invasive mechanical ventilation, parenteral nutrition, and
hospital stay.
Statistical analyses were performed using open-source
statistical R 3.5.1 software (R Foundation for Statistical
Computing, Vienna, Austria), with chi-square tests and Fish-
er’s tests for categorical variables and Student’s t-tests,
Wilcoxon tests, and Kruskal–Wallis-tests for continuous
variables; p  0.05 was considered signiﬁcant.
Results
During the 2-year study period, the incidence of pathological
MetHb was 6% (11/182 eligible newborns), excluding
patients treated with NO for pulmonary hypertension or
with cyanotic heart diseases.
In the case and control groups, 91% of patients were
preterm, with a mean gestational age of 326/7 weeks
(range: 241/7–371/7 weeks). The mean birth weight was
2,063 g (range: 665–3,470 g). All patients were in very
critical conditions at admission (SNAP/SNAPPE-II 13/25). Of
the infants, 64% were admitted for gastrointestinal con-
genital malformations and 36% for necrotizing enterocoli-
tis; 91% of patients underwent surgery during hospital stay.
Male newborns seem to be more affected by MetHb (seven
males vs. four females; p ¼ 0.36). The mean MetHb in the
case group was 7.2% (range: 2.3–17%). The ﬁrst positive
samples were observed at a mean of 22 days of life (range:
8–48 days of life) and 6 days prior to the onset of clinical or
culture-proven sepsis (range: 1–8 days). The maximum
concentration was found at 37 days of life (range: 22–83
days of life).
At the same gestational age, birth weight, and SNAP/
SNAPPE-II score, MetHb was associated with lower maternal
age at delivery (31 vs. 34 years; p ¼ 0.038); no other mater-
nal risk factors (smoking, pregravidic diseases, medica-
ments) nor vitamin supplementation showed statistical
signiﬁcance.
The average length of hospital stay was longer in MetHb
patients, and four infants did not survive (mortality rate:
36%). Nonsurvivors showed higher trends in MetHb peak
values (10.8 vs. 4.1%; p ¼ 0.34).
CirculatingMetHbwas signiﬁcantly higher in infants with
clinical sepsis (3.8 vs. 1.7%; p ¼ 0.022). The most frequent
culture-proven sepsis was due to Staphylococcus spp. Dura-
tion of parenteral nutrition was longer in the case group (46
vs 23 days; p ¼ 0.013), whereasminimal enteral feeding was
tolerated earlier in the control group (12th vs. 9th day;
p ¼ 0.038). Pharmacological therapy, vitamin supplementa-
tion, parenteral nutrition, lipid emulsion, and transfusion
did not show correlation with MetHb (►Table 1). Two
cyanotic patients withMetHb values > 15% required methy-
lene blue treatment and subsequent high intake of antiox-
idant vitamins until methemoglobin normalized. The others
recovered spontaneously with ﬂuid resuscitation and spe-
ciﬁc sepsis therapies.
Discussion
MetHb is a hidden problem in NICU as evidenced by the
unexpectedly high incidence rate, despite the high cutoff
value of MetHb, >1.8%, selected to minimize inclusion of
patients with transitory or accidental increase.
Infants exposed in NICU to excessive oxidizing agents are
particularly susceptible to oxidative stress and consequently
to the development of MetHb because the antioxidant
enzyme activities in erythrocytes, such as glutathione per-
oxidase, catalase, and methemoglobin reductase, are
reduced compared with adults.15,16 Moreover, the still pre-
dominant fetal Hb leads to more susceptibility to oxidation.
In this study, almost all newbornswithMetHbwere preterm,
conﬁrming the role of enzymatic immaturity in the devel-
opment of pathology.
Other reported that risk factors can be concomitant
clinical conditions, such as anemia, acidosis, respiratory
compromise, cardiocirculatory failure, slow intestinal tran-
sit, and dysbiosis in surgical patients. These comorbidities
may contribute to the further formation of superoxide
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radicals, hydrogen peroxide, or NO, which lead to methe-
moglobin overproduction.2
Our patients with MetHb showed a high rate of clinical or
culture-proven sepsis. In adult and children, this association
has been described, particularly in patients with diarrhea4
and gastrointestinal inﬂammation,17 independent of acci-
dental exposure to nitrate-contaminated water or food.18
Few studies report an association between MetHb and
Staphylococcus aureus infection.19,20
In sepsis, large amounts of NO are released by activated
endothelial cells. NO interacts with Hb, forming methemo-
globin and nitrate (NO3).
These nitrates (NO3) can be transformed into nitrite (NO2)
and subsequently to other NO in the presence of nitrate
reductase producing bacteria, initiating a vicious circle of
severe MetHb.2,21
In our population, the sepsis-related MetHb might inter-
act with dysbiosis in the gut microbiota due to delayed
enteral nutrition in susceptible surgical patients.
Infectious etiology is also supported by the fact that no
other exogenous sources of oxidative stress have been iden-
tiﬁed and that the medical treatment of similar pathologies
was homogeneous in both groups. Furthermore, the ﬁrst
increase of MetHb was not correlated to local or systemic
anesthetics since it occurred without temporal correlation
with surgical interventions. However, the use of a local
anesthetic cream (lidocaine/prilocaine) was strictly limited
to term newborns in both groups.
Despite thehigh incidenceofMetHbobserved inour study, it
seems to be an underdiagnosed and not considered pathologi-
cal condition in the NICU because poorly symptomatic at levels
below10% andwith unspeciﬁc clinicalmanifestations at higher
levels. In modern blood gas analyzers, MetHb can be easily
detected and monitored. We can suppose that some cases of
MetHb secondary to speciﬁc diseases remain undetected
because they rapidly recover by treating the underlying illness.
The limits of this study are the small case group and the
retrospective design. However, the statistical analyses can be
considered reliable, thanks to the rigorousmatching protocol
that reduce biases.
A multicenter prospective study is warranted to further
analyze the time of onset and the progression and resolution
of MetHb in relation to the identiﬁed risk factors (low
maternal age, prematurity, Staphylococcus-related late-onset
sepsis, and protracted parenteral nutrition). This would
allow to conﬁrm not only if MetHb has high frequency in
NICU but also if it is a prognostic factor for sepsis.
Conclusion
As described in older children and adults, even in newborns,
MetHb can be an indicator of an infectious process linked to
nitrate-reducing bacteria.
It is important for the pediatrician to take MetHb into
account in the differential diagnosis of cyanosis and hypoxia.
The understanding of the potential etiology and the prompt
identiﬁcation of the MetHb can allow to implement a poten-
tially life-saving therapy.
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